Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Revvity cuts annual forecast on weak demand for diagnostics, contract research
(Reuters) - Revvity Inc cut its full-year sales and revenue forecasts after missing Wall Street estimates for third-quarter results, hurt by weak demand for its supplies to life science researchers an...
Oct 30, 2023
Amplifon lowers profit forecast on weak European market, shares drop
(Reuters) -Italian hearing aid maker Amplifon lowered its full year guidance for recurring core profit on Monday, citing weaker than expected demand in Europe and global economic and political uncerta...
Oct 30, 2023
Pharmacy staff from CVS, Walgreens stores in US plan 3-day walkout
By Leroy Leo (Reuters) - Thousands of employees at CVS Health Corp and Walgreens Boots Alliance's U.S. pharmacies are planning a three-day walkout starting Monday, in an attempt to get the companies t...
Oct 30, 2023
Reviva Pharma’s schizophrenia drug succeeds in late-stage study
(Reuters) -Reviva Pharmaceuticals Holdings said on Monday its lead experimental drug to treat adults with schizophrenia helped reduce disease symptoms in a late-stage study. Schizophrenia is a chronic...
Oct 30, 2023
Healthpeak, Physicians Realty to merge in $2.64 billion stock deal
(Reuters) -Healthpeak Properties and Physicians Realty Trust have agreed to combine in a $2.64 billion all-stock deal, the companies said on Monday. The new entity will operate under the Healthpeak Pr...
Oct 30, 2023
Pfizer RSV vaccine lags GSK’s as head-to-head competition underway
By Michael Erman (Reuters) - Pfizer, which dominated COVID vaccine sales, now finds itself looking up at GSK, whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead sinc...
Oct 30, 2023
Everstone hires BDA to sell $1 billion Singapore healthcare services firm Everlife – sources
By Kane Wu and Yantoultra Ngui HONG KONG/SINGAPORE (Reuters) - Singapore-headquartered private equity firm Everstone Capital has hired BDA Partners to run a sale of Everlife Holdings that could value ...
Oct 30, 2023
Merck KGaA widens work on ‘DNA damage’ drugs in deal with China’s Hengrui
FRANKFURT (Reuters) - Germany's Merck KGaA on Monday said it struck a collaboration deal with Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to widen Merck's work in an area known as "DNA damage re...
Oct 30, 2023
Novartis says drug candidate is successful in rare kidney disease trial
FRANKFURT (Reuters) - Novartis said its experimental drug atrasentan was shown to have a positive effect on kidney function in people suffering from a rare type of kidney disease in an interim analysi...
Oct 30, 2023
GSK says endometrial cancer drug meets overall survival goal in late-stage trial
(Reuters) -British drugmaker GSK said on Monday its cancer drug Jemperli, when combined with chemotherapy, met the primary goal of overall survival in patients with primary advanced or recurrent endom...
Oct 30, 2023
